CureVac Announces Financial Results for the Fourth Quarter a

Issuer: CureVac


/ Key word: Annual Results





CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update






24.04.2024 / 13:06...

Related Keywords

Germany , Belgium , Netherlands , United States , Virginia , United Kingdom , Texas , Switzerland , Federal Republic Of Germany , German , Sarah Fakih , Thaminda Ramanayake , Pierre Kemula , Patrick Perez , Alexander Zehnder , University Of Rochester Simon School Business , Clinical Trial Supply Agreement Center , Junior , Curevac Inc , Exchange Commission , Amgen , Corporate Development , Seasonal Flu Program , German Federal Patent Court , Corporate Communications , University Of Rochester , Biomarin Pharmaceuticals , University Of Texas Md Anderson Cancer Center , Rna Vaccine Program , District Court , Curevac Corporate Services Gmb , German Federal Court , German Center , Curevac Management Team , German Federal Ministry Of Health , Regional Court , Curevac Announces Financial Results , Fourth Quarter , Provides Business , Pandemic Preparedness Agreement , Federal Republic , German Federal Ministry , Chief Business Officer , Chief Executive Officer , Chief Financial Officer , Pandemic Vaccines , Cancer Center , Affinit Therapeutics , Vice President , Global Head , Business Development , Rochester Simon School , Broad Second Generation , Jointly Developed , Oncology Footprint , Data Safety Monitoring Board , Intellectual Property , Acuitas Therapeutics , Eastern District , Finance Income , Junior Manager Public , Vice President Corporate Communications , Curevac Manufacturing Gmbh , Curevac Swiss , Curevac Corporate Services Gmbh , Curevac Belgium , Condensed Consolidated Profit , Operating Expenses ,